NPDC1 Antilichaam - N-terminalgebied: FITC (ARP47153_T100-FITC)

Neural proliferation, differentiation and control, 1

CAB, CAB-, CAB1, CAB-1, NPDC-1

56654

Q9NQX5

NP_056207

Human, Mouse, Rat, Cow, Dog, Yeast

The immunogen is a synthetic peptide directed towards the N terminal region of human NPDC1

NPDC1 suppresses oncogenic transformation in neural and non-neural cells and down-regulates neural cell proliferation. It might be involved in transcriptional regulation.

NOTCH2NL; KRTAP10-3; KRTAP10-5; KRTAP10-1; KRTAP10-9; KRTAP10-7; KHDRBS2; UBC; MDFI; KRTAP5-9; CPT1A; HINFP; KRTAP4-12; NPDC1; PLSCR1; MADD; HNRNPK; E2F1; TFDP1; CCND1; CCND3; CCND2; CDK2

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

0.5 mg/ml

Cow: 93%; Dog: 93%; Human: 100%; Mouse: 93%; Rat: 93%; Yeast: 83%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

34kDa

Evrard, C., (2004) Gene 343 (1), 153-163

Wet Ice

325

NPDC1

NPDC1

Rabbit

Neural proliferation differentiation and control protein 1

NM_015392

MATPLPPPSPRHLRLLRLLLSGLVLGAALRGAAAGHPDVAACPGSLDCAL